The Current Ratio as of November 2024 (TTM) for Aadi Bioscience, Inc. (AADI) is 4.20

According to Aadi Bioscience, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.20. This represents a change of -18.29% compared to the average of 5.14 of the last 4 quarters.

Aadi Bioscience, Inc. (AADI) Historical Current Ratio (quarterly & annually)

How has AADI Current Ratio performed in the past?

The mean historical Current Ratio of Aadi Bioscience, Inc. over the last ten years is 5.72. The current 4.20 Current Ratio has changed 7.25% with respect to the historical average. Over the past ten years (40 quarters), AADI's Current Ratio was at its highest in in the September 2020 quarter at 19.74. The Current Ratio was at its lowest in in the December 2016 quarter at 0.02.

Aadi Bioscience, Inc. (AADI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aadi Bioscience, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aadi Bioscience, Inc. (AADI) Average Current Ratio

How has AADI Current Ratio performed in the past?

The current Current Ratio of Aadi Bioscience, Inc. (AADI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aadi Bioscience, Inc. (AADI) Current Ratio vs. Peers

How is AADI’s Current Ratio compared to its peers?

Aadi Bioscience, Inc.’s Current Ratio is less than Anebulo Pharmaceuticals, Inc. (13.46), greater than Adagene Inc. (2.50), less than Acrivon Therapeutics, Inc. Common Stock (16.16), less than AnaptysBio, Inc. (9.09), less than Mineralys Therapeutics, Inc. (11.20), less than AN2 Therapeutics, Inc. (10.61), less than Aerovate Therapeutics, Inc. (6.51), less than Gracell Biotechnologies Inc. (7.73), less than Theseus Pharmaceuticals, Inc. (29.93), less than Monte Rosa Therapeutics, Inc. (6.56), less than Design Therapeutics, Inc. (41.42), less than Erasca, Inc. (16.79), less than Rezolute, Inc. (13.39), greater than Ultragenyx Pharmaceutical Inc. (3.54), less than Crinetics Pharmaceuticals, Inc. (16.09), greater than Arvinas, Inc. (4.17), less than Revolution Medicines, Inc. (15.42), less than Kura Oncology, Inc. (14.94),

Build a custom stock screener for Aadi Bioscience, Inc. (AADI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aadi Bioscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aadi Bioscience, Inc. (AADI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aadi Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.